Related references
Note: Only part of the references are listed.TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop
Carmine Settembre et al.
NATURE CELL BIOLOGY (2013)
Putative Biological Mechanisms of Efficiency of Substrate Reduction Therapies for Mucopolysaccharidoses
Zyta Banecka-Majkutewicz et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2012)
A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
Carmine Settembre et al.
EMBO JOURNAL (2012)
Changes in hair morphology as a biomarker in gene expression-targeted isoflavone therapy for Sanfilippo disease
Magdalena Narajczyk et al.
GENE (2012)
Gene expression-targeted isoflavone therapy
Alicja Wegrzyn
IUBMB LIFE (2012)
Genetic Analyses of Heme Oxygenase 1 (HMOX1) in Different Forms of Pancreatitis
Sebastian Weis et al.
PLOS ONE (2012)
Substrate Reduction Therapies for Mucopolysaccharidoses
Joanna Jakobkiewicz-Banecka et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Transcriptional Activation of Lysosomal Exocytosis Promotes Cellular Clearance
Diego L. Medina et al.
DEVELOPMENTAL CELL (2011)
Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways
Michela Palmieri et al.
HUMAN MOLECULAR GENETICS (2011)
Genistein supplementation in patients affected by Sanfilippo disease
Veronica Delgadillo et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2011)
TFEB Links Autophagy to Lysosomal Biogenesis
Carmine Settembre et al.
SCIENCE (2011)
Genistein: a natural isoflavone with a potential for treatment of genetic diseases
Grzegorz Wegrzyn et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II
A. Friso et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Impairment of glycosaminoglycan synthesis in mucopolysaccharidosis type IIIA cells by using siRNA: a potential therapeutic approach for Sanfilippo disease
Dariusz Dziedzic et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2010)
Storage correction in cells of patients suffering from mucopolysaccharidoses types IIIA and VII after treatment with genistein and other isoflavones
Audrey Arfi et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different?
Grzegorz Wegrzyn et al.
MEDICAL HYPOTHESES (2010)
Genistein Improves Neuropathology and Corrects Behaviour in a Mouse Model of Neurodegenerative Metabolic Disease
Marcelina Malinowska et al.
PLOS ONE (2010)
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eran Eden et al.
BMC BIOINFORMATICS (2009)
Lysosomal enhancement A CLEAR answer to cellular degradative needs
Marco Sardiello et al.
CELL CYCLE (2009)
Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway
Todd M. Morgan et al.
CURRENT CANCER DRUG TARGETS (2009)
Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice
Marcelina Malinowska et al.
MOLECULAR GENETICS AND METABOLISM (2009)
Monoamine oxidase A gene (MAOA) predicts behavioral aggression following provocation
Rose McDermott et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A Gene Network Regulating Lysosomal Biogenesis and Function
Marco Sardiello et al.
SCIENCE (2009)
Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway
Joanna Jakobkiewicz-Banecka et al.
JOURNAL OF BIOMEDICAL SCIENCE (2009)
Genistin-rich soy isoflavone extract in substrate reduction therapy for Sanfilippo syndrome:: An open-label, pilot study in 10 pediatric patients
Ewa Piotrowska et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2008)
Genistein attenuates oxidative stress and neuronal damage following transient global cerebral ischemia in rat hippocampus
Hua-Wei Liang et al.
NEUROSCIENCE LETTERS (2008)
Gene therapy for mucopolysaccharidosis
Katherine P. Ponder et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Treatment of lysosomal storage disorders - Progress with enzyme replacement therapy
Marianne Rohrbach et al.
DRUGS (2007)
Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses
Ewa Piotrowska et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2006)
Water-soluble genistin glycoside isoflavones up-regulate antioxidant metallothionein expression and scavenge free radicals
Mi Ja Chung et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2006)
From genomics to chemical genomics: new developments in KEGG
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper - Excel-based tool using pair-wise correlations
MW Pfaffl et al.
BIOTECHNOLOGY LETTERS (2004)
Apoptosis induced by exposure to a low steady-state concentration of H2O2 is a consequence of lysosomal rupture
F Antunes et al.
BIOCHEMICAL JOURNAL (2001)
The molecular basis of lysosomal storage diseases and their treatment
B Winchester et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2000)
Share Paper
